Welcome to LookChem.com Sign In|Join Free

CAS

  • or

84827-40-7

Post Buying Request

84827-40-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

84827-40-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 84827-40-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,8,2 and 7 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 84827-40:
(7*8)+(6*4)+(5*8)+(4*2)+(3*7)+(2*4)+(1*0)=157
157 % 10 = 7
So 84827-40-7 is a valid CAS Registry Number.

84827-40-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(2,3-dihydro-1H-inden-5-ylamino)acetate

1.2 Other means of identification

Product number -
Other names Ethyl (2,3-Dihydro-1H-inden-5-ylamino)acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:84827-40-7 SDS

84827-40-7Relevant articles and documents

N-substituted-amido-amino acids

-

, (2008/06/13)

Compounds of the formula STR1 wherein R and R9 are independently hydroxy or lower alkoxy, R1 and R2 are hydrogen or lower alkyl, aryl-lower alkyl having from 7 to 12 carbon atoms, or heterocyclic-lower alkyl having from 6

Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives

Stanton,Gruenfeld,Babiarz,Ackerman,Friedmann,Yuan,Macchia

, p. 1267 - 1277 (2007/10/02)

The synthesis of N-(3-mercaptopropionyl)-N-arylglycines (14a-x), -N-arylalanines (15a,b), -N-cycloalkylglycines (16a-k), and -1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids (17a-d), -1,2,3,4-tetrahydroquinoline-2-carboxylic acids (18a-f), and -indoline-2-carboxylic acids (19a-k) is described. In vitro inhibition of angiotensin converting enzyme (ACE) is reported for each compound, and the structure-activity relationship for each series is discussed. The in vivo inhibition of ACE and antihypertensive effects of representative compounds from each series are discussed. The most potent compound, 19d, had an in vitro ACE IC50 of 2.6 x 10-9 M and lowered blood pressure in spontaneous hypertensive rats 85 mm at a dose of 10 mg/kg po.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 84827-40-7